Skip to content
Screener

Radient Pharmaceuticals Corporation RPC Q1 2026 earnings

Reported May 7, 2026 · Before market open

Revenue$75.0MMiss by $2.0M
EPS$0.22Beat by $0.01
Revenue estimate$77.0M
EPS estimate$0.21

Next report

Aug 5, 2026 (Tomorrow)
Revenue estimate$80.8M
EPS estimate$0.23

Versus estimates

Revenue

Q1 2026$75.0MMiss by $2.0M
Q4 2025$81.0MBeat by $1.6M

Diluted EPS

Q1 2026$0.22Beat by $0.01
Q4 2025$0.26Beat by $0.01

FAQ

When did Radient Pharmaceuticals Corporation report Q1 2026 earnings?
Radient Pharmaceuticals Corporation (RPC) reported Q1 2026 earnings on May 7, 2026 before market open.
What were Radient Pharmaceuticals Corporation's Q1 2026 revenue and EPS?
Radient Pharmaceuticals Corporation reported revenue of $75.0M and eps of $0.22 for Q1 2026.
Did Radient Pharmaceuticals Corporation beat estimates in Q1 2026?
Revenue missed the consensus estimate of $77.0M by $2.0M. EPS beat the consensus estimate of $0.21 by $0.01.
Where can I find Radient Pharmaceuticals Corporation's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-213371) and the 10-Q periodic report (0001193125-26-213908) directly on SEC EDGAR. The filing index links above go to sec.gov.